Physical factor therapies for insomnia: a narrative review of mechanisms, clinical evidence, and phenotype-guided applications - Scorecard - MDSpire

Physical factor therapies for insomnia: a narrative review of mechanisms, clinical evidence, and phenotype-guided applications

  • By

  • Shuhui Li

  • Qiubai Long

  • Dongfeng Huang

  • Yurong Mao

  • June 22, 2026

  • 0 min

Share

Clinical Scorecard: Non-Pharmacological Approaches to Insomnia: A Comprehensive Review of Mechanisms, Clinical Evidence, and Phenotype-Specific Applications of Physical Factor Therapies

At a Glance

CategoryDetail
ConditionInsomnia
Key MechanismsHyperarousal, circadian entrainment, thermoregulatory promotion of sleep, autonomic balance restoration
Target PopulationAdults with insomnia symptoms or diagnosed insomnia disorder
Care SettingClinical and home-based settings for non-pharmacological interventions

Key Highlights

  • Physical factor therapies include auditory stimulation, phototherapy, thermotherapy, electrical stimulation, and magnetic stimulation.
  • Insomnia affects approximately 10-15% of adults, with higher prevalence in women and older adults.
  • Cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment, while pharmacotherapy is reserved for short-term use.
  • Current evidence for physical factor therapies is heterogeneous and preliminary.
  • Future research should focus on larger trials and standardized protocols.

Guideline-Based Recommendations

Diagnosis

  • Insomnia is diagnosed based on symptoms occurring at least three times per week for a minimum of three months.

Management

  • Cognitive behavioral therapy for insomnia (CBT-I) is recommended as the first-line treatment.

Monitoring & Follow-up

  • Monitor for daytime impairment and associated health outcomes.

Risks

  • Long-term pharmacological treatments carry risks of tolerance and dependence.

Patient & Prescribing Data

Adults experiencing insomnia symptoms or diagnosed insomnia disorder.

Non-pharmacological interventions may serve as adjunctive options for selected insomnia phenotypes.

Clinical Best Practices

  • Consider non-pharmacological approaches for patients with insomnia to mitigate risks associated with long-term medication use.
  • Utilize evidence-based therapies tailored to individual patient needs and insomnia phenotypes.

Related Resources & Content

Original Source(s)

Related Content